메뉴 건너뛰기
International Journal of Pharmaceutics
Volumn 415, Issue 1-2, 2011, Pages 2-4
Genomics and personalized medicine
Author keywords

[No Author keywords available]
Indexed keywords

BIOLOGICAL MARKER; CLOPIDOGREL; CODEINE; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; TAMOXIFEN; WARFARIN;
EID: 79960156076     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.04.048     Document Type: Editorial
Times cited : (19)
References (9)
  • 1
    • 39449137238 scopus 로고    scopus 로고
    • Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
    • DOI 10.1097/GIM.0b013e318163c35f, PII 0012581720080200000010
    • D.A. Flockhart, D. O'Kane, M.S. Williams, B. Watson, and B. Gage ACMG Working Group on Pharmacogenetic testing of CYP2C9, VKORC1 allele for warfarin use Genet. Med. 10 2008 139 150 (Pubitemid 351271726)
    • (2008) Genetics in Medicine , vol.10 , Issue.2 , pp. 139-150
    • Flockhart, D.A.1    O'Kane, D.2    Williams, M.S.3    Watson, M.S.4
  • 3
    • 57149130819 scopus 로고    scopus 로고
    • Drug Therapy and personalized health care: Pharmacogenetics in perspective
    • W. Sadee Drug Therapy and personalized health care: pharmacogenetics in perspective Pharm. Res. 25 2008 2712 2719
    • (2008) Pharm. Res. , vol.25 , pp. 2712-2719
    • Sadee, W.1
  • 4
    • 74749106489 scopus 로고    scopus 로고
    • Regulatory polymorphisms in key candidate genes for disease susceptibility and drug response: A mandate for valid genetic biomarkers
    • W. Sadee Regulatory polymorphisms in key candidate genes for disease susceptibility and drug response: a mandate for valid genetic biomarkers Exp. Rev. Mol. Diagn. 10 2010 9 11
    • (2010) Exp. Rev. Mol. Diagn. , vol.10 , pp. 9-11
    • Sadee, W.1
  • 5
    • 27744463332 scopus 로고    scopus 로고
    • Pharmacogenetics/genomics and personalized medicine
    • W. Sadee, and Z. Dai Pharmacogenetics/genomics and personalized medicine Hum. Mol. Genet. 14 2005 R207 R214
    • (2005) Hum. Mol. Genet. , vol.14
    • Sadee, W.1    Dai, Z.2
  • 6
    • 69249219296 scopus 로고    scopus 로고
    • Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidrogel therapy
    • A.R. Shuldiner, J.R. O'Connell, and K.P. Bliden Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidrogel therapy J. Am. Med. Assoc. 302 2009 849 857
    • (2009) J. Am. Med. Assoc. , vol.302 , pp. 849-857
    • Shuldiner, A.R.1    O'Connell, J.R.2    Bliden, K.P.3
  • 7
    • 49949104757 scopus 로고    scopus 로고
    • SLCO1B1 variants and statin-induced myopathy - A genome-wide study
    • The Search Collaborative Group
    • The Search Collaborative Group SLCO1B1 variants and statin-induced myopathy - a genome-wide study New Engl. J. Med. 359 2008 789 799
    • (2008) New Engl. J. Med. , vol.359 , pp. 789-799
  • 8
    • 51649084617 scopus 로고    scopus 로고
    • Regulatory polymorphism in vitamin K epoxide reductase complex subunit i (VKORC1) affects gene expression and warfarin dose requirement
    • D. Wang, H. Chen, K.M. Momary, I.H. Cavallari, J.A. Johnson, and W. Sadee Regulatory polymorphism in vitamin K epoxide reductase complex subunit I (VKORC1) affects gene expression and warfarin dose requirement Blood 112 2008 1013 1201
    • (2008) Blood , vol.112 , pp. 1013-1201
    • Wang, D.1    Chen, H.2    Momary, K.M.3    Cavallari, I.H.4    Johnson, J.A.5    Sadee, W.6
  • 9
    • 56149103903 scopus 로고    scopus 로고
    • The remerging concept of personalized health care
    • I.H. Xu, H. Zheng, D.D. Sedmak, and W. Sadee The remerging concept of personalized health care Pers. Med. 5 2008 457 469
    • (2008) Pers. Med. , vol.5 , pp. 457-469
    • Xu, I.H.1    Zheng, H.2    Sedmak, D.D.3    Sadee, W.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.